River Road Asset Management LLC Purchases 376,958 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

River Road Asset Management LLC lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 439.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 462,660 shares of the company’s stock after buying an additional 376,958 shares during the quarter. River Road Asset Management LLC’s holdings in GE HealthCare Technologies were worth $35,773,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in GEHC. Archer Investment Corp boosted its holdings in shares of GE HealthCare Technologies by 404.6% in the 4th quarter. Archer Investment Corp now owns 661 shares of the company’s stock valued at $51,000 after purchasing an additional 530 shares in the last quarter. Rakuten Securities Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at $78,000. SVB Wealth LLC boosted its holdings in shares of GE HealthCare Technologies by 7.5% in the 4th quarter. SVB Wealth LLC now owns 6,126 shares of the company’s stock valued at $474,000 after purchasing an additional 425 shares in the last quarter. Capital Analysts LLC boosted its holdings in shares of GE HealthCare Technologies by 938.6% in the 4th quarter. Capital Analysts LLC now owns 457 shares of the company’s stock valued at $35,000 after purchasing an additional 413 shares in the last quarter. Finally, Sippican Capital Advisors boosted its holdings in shares of GE HealthCare Technologies by 3.4% in the 4th quarter. Sippican Capital Advisors now owns 16,891 shares of the company’s stock valued at $1,306,000 after purchasing an additional 552 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.8 %

Shares of GEHC stock traded down $0.69 during mid-day trading on Wednesday, hitting $85.19. The company’s stock had a trading volume of 1,711,216 shares, compared to its average volume of 3,426,849. The company’s fifty day simple moving average is $88.55 and its 200-day simple moving average is $77.60. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The company has a market cap of $38.87 billion, a PE ratio of 28.32, a P/E/G ratio of 3.00 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period last year, the company posted $1.31 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Analysts Set New Price Targets

GEHC has been the subject of a number of research reports. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Mizuho increased their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Argus increased their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Citigroup increased their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, Morgan Stanley increased their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.